参考文献/References:
[1] RONG Yan, MAYO P, ENSOM M H H, et al.
Population pharmacokinetics of mycophenolic acid
Coadministered with tacrolimus in corticosteroidfree
adult kidney transplant patients [J]. Clin
Pharmacokinet, 2019,58(11):1483-1495.
[2] 郭晨煜，王科，孙永旭，等. 肾移植患者他克莫司
血药浓度与肝肾毒性分析[J]. 临床肾脏病杂志，
2014，14(8)：484-487.
GUO Chenyu，WANG Ke，SUN Yongxu，et al.
Analysis of the relationship between tacrolimus blood
concentration with hepatotoxicity and nephrotoxicity
in kidney transplant recipients [J]. Journal of Clinical
Nephrology，2014，14(8)：484-487.
[3] FERJANI H，EL AREM A，BOURAOUI A，
et al. Protective effect of mycophenolate mofetil
against nephrotoxicity and hepatotoxicity induced
by tacrolimus in Wistar rats[J]. J Physiol Biochem，
2016，72(2)：133-144.
[4] VICARI-CHRISTENSEN M，REPPER S，BASILE
S, et al. Tacrolimus：review of pharmacokinetics，
pharmacodynamics，and pharmacogenetics to facilitate
practitioners’ understanding and offer strategies for
educating patients and promoting adherence [J]. Prog
Transplant， 2009，19(3)：277-284.
[5] ZHU Lin，ZHANG Jing，SONG Hongtao，et al.
Relationships of related genetic polymorphisms and
individualized medication of tacrolimus in patients
with renal transplantation[J]. International Journal of
Clinical & Experimental Medicine，2015，8(10)：
19006-19013.
[6] EKBERG H，TEDESCO-SILVA H，DEMIRBAS
A，et al. Reduced exposure to calcineurin inhibitors
in renal transplantation.[J]. N Engl J Med，2007，
357(25)：2562-2575.
[7] TH?LKING G，FORTMANN C，KOCH R，et
al. The tacrolimus metabolism rate influences renal
function after kidney transplantation[J]. PLoS One，
2014，9(10)：e111128.
[8] TOKI D，OKUMI M， INUI M，et al. Glomerular
abnormalities associated with chronic calcineurin
inhibitor nephrotoxicity in late renal allograft
biopsies[J]. Transplantation，2018，102：S490.
[9] TH?LKING G，GERTH H U，SCHUETTENUETGEN
K，et al. Influence of tacrolimus
metabolism rate on renal function after solid organ
transplantation[J]. World Journal of Transplantation，
2017，7(1)：26-33.
[10] 李佳，廖丽雯，孙萍萍，等. 118 例肾移植患者他
克莫司血药谷浓度与肝肾功能及血常规指标的关系
[J]. 中国医院药学杂志，2016，36(3)：219-222.
LI Jia，LIAO Liwen，SUN Pingping，et al.
Correlation of blood though concentration of tacrolimus
with results of hepatic functions，renal functions
and routine blood test in 118 patients after renal
transplantation[J]. Chin Hosp Pharm J，2016，36(3)：
219-222.
[11] 孙艺哲，张平安. 肾移植患者他克莫司血药谷浓度
与肝肾功能及血常规指标的关系[J]. 贵州医药，
2019，43(1)：79-82.
SUN Yizhe，ZHANG Ping’an.Relationship between
tacrolimus concentration and results of liver and
renal function routine blood test in renal transplant
patients[J]. Guizhou Medical Journal，2019，43(1)：
79-82.
[12] 牛志立，张平安. 肾移植患者FK506 浓度与肝肾
功能、血常规指标的关系[J]. 现代检验医学杂志，
2013，28(5)：123-125.
NIU Zhili，ZHANG Ping’an. Relationship between
FK506 concentration and results of liver and renal
function routine blood test in renal transplant patients
[J]. Journal of Modern Laboratory Medicine，2013，
28(5)：123-125.
[13] 秦伟，王晓雪，张相林，等. 他克莫司浓度在移植
患者全血、血浆与血细胞中的相关性研究[J]. 中国
药房，2019，30(15)：2105-2110.
QIN Wei，WANG Xiaoxue，ZHANG Xianglin，
et al. Correlation of tacrolimus concentrations among
transplant patients’ whole blood， plasma and blood
cells[J].China Pharmacy，2019，30(15)：2105-2110.
[14] 张鹰，龚菁，谢能轩. 他克莫司不同血药浓度对肾
移植患者肝肾功能的影响[J]. 抗感染药学，2018，
15(9)：1569-1570.
ZHANG Ying, GONG Jing, XIE Nengxuan. The effect
of the different blood concentration of tacrolimus on
renal and hepatic fuction in renal transplant patients[J].
Anti Infect Pharm，22018，15(9)：1569-1570.